Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Landers

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
JAMA|December 12, 1986
Medical care costs of AIDS in MassachusettsG R Seage, S Landers, A Barry, et al.
Somatosensory & Motor Research|July 10, 2003
Characterizing the functional significance of the neonatal rat vibrissae prior to the onset of whiskingRegina M Sullivan, Margo S Landers, Jennifer Flemming, et al.
American Journal of Public Health|August 1, 1988
Medical costs of ambulatory patients with AIDS-related complex (ARC) and/or generalized lymphadenopathy syndrome (GLS) related to HIV infection, 1984-85G R Seage, S Landers, K H Mayer, et al.
American Journal of Preventive Medicine|October 24, 2008
Integrating screening and interventions for unhealthy behaviors into primary care practicesCheryl B Aspy, James W Mold, David M Thompson, et al.
Journal of Human Virology|September 16, 2000
Immune responses to a recombinant human immunodeficiency virus type 1 (HIV-1) gpl60 vaccine among adults with advanced HIV infection. Massachusetts gp160 Working GroupA DeMaria, L Kunches, K Mayer, et al.
Cancer Research|December 5, 2000
Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trialJ Nemunaitis, I Ganly, F Khuri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancerJ Nemunaitis, F Khuri, I Ganly, et al.
Frontiers in Physiology|August 19, 2024
Reproductive neuroendocrine defects programmed by prenatal testosterone treatment between gestational days 60-90 are amplified by postnatal obesity in sheepS C Gurule, J F Sustaita-Monroe, L N King, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
JAMA|December 12, 1986
Medical care costs of AIDS in MassachusettsG R Seage, S Landers, A Barry, et al.
Somatosensory & Motor Research|July 10, 2003
Characterizing the functional significance of the neonatal rat vibrissae prior to the onset of whiskingRegina M Sullivan, Margo S Landers, Jennifer Flemming, et al.
American Journal of Public Health|August 1, 1988
Medical costs of ambulatory patients with AIDS-related complex (ARC) and/or generalized lymphadenopathy syndrome (GLS) related to HIV infection, 1984-85G R Seage, S Landers, K H Mayer, et al.
American Journal of Preventive Medicine|October 24, 2008
Integrating screening and interventions for unhealthy behaviors into primary care practicesCheryl B Aspy, James W Mold, David M Thompson, et al.
Journal of Human Virology|September 16, 2000
Immune responses to a recombinant human immunodeficiency virus type 1 (HIV-1) gpl60 vaccine among adults with advanced HIV infection. Massachusetts gp160 Working GroupA DeMaria, L Kunches, K Mayer, et al.
Cancer Research|December 5, 2000
Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trialJ Nemunaitis, I Ganly, F Khuri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancerJ Nemunaitis, F Khuri, I Ganly, et al.
Frontiers in Physiology|August 19, 2024
Reproductive neuroendocrine defects programmed by prenatal testosterone treatment between gestational days 60-90 are amplified by postnatal obesity in sheepS C Gurule, J F Sustaita-Monroe, L N King, et al.
Pageof 4